Plasma Rich in Growth Factors (PRGF) Treatment for Muscle Tear

Clalit Health Services

Status and phase: Completed; Phase 3; Phase 2

Conditions: Muscle Tear

Treatments: Biological: PRGF; Biological: Placebo

Study type: Interventional

Funder types: Other

Identifiers

NCT00726245

3000

Details and patient eligibility

About

the improvement of symptoms and disease progress by the treatment of OA of the knee with PRGF

Enrollment: 50 estimated patients

Sex: All

Ages: 15 to 40 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• US diagnosed muscle tear
• age 15-40 years old

Exclusion criteria

• pregnancy
• mental or physical disabilities

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: Double Blind

---

50 participants in 2 patient groups, including a placebo group

1

Experimental group

Description:

PRGF

Treatment:

Biological: PRGF

2

Placebo Comparator group

Description:

physiological saline

Treatment:

Biological: Placebo